Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thrombotic Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02085993
What this trial is testing

Study of Patients With ITP Estimating the Proportion Administering Romiplostim Correctly After Receiving Home Administration Training

Who this might be right for
Immune Thrombocytopenic Purpura
Amgen 41
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07400250
What this trial is testing

Phase II Study of Orelabrutinib in Combination With Romiplostim N01 in Patients With Primary Immune Thrombocytopenia (ITP) Who Have Received At Least One Prior Line of Therapy

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Peking Union Medical College Hospital 28
Not applicableStudy completedNCT04902807
What this trial is testing

Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation

Who this might be right for
Autoimmune Lymphoproliferative SyndromeAutoimmune CytopeniaAutoimmune Diseases+17 more
Institut National de la Santé Et de la Recherche Médicale, France 325
Not applicableStudy completedNCT01428765
What this trial is testing

GLORIA-AF Registry Program (Phase I)

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 1,096
Large-scale testing (Phase 3)UnknownNCT00474591
What this trial is testing

Fondaparinux to Prevent Thrombotic Complications and Graft Failure in Patients Undergoing Coronary Artery Bypass Graft Surgery: The Fonda CABG Study

Who this might be right for
Coronary Bypass Graft Failure/Occlusion
Hamilton Health Sciences Corporation 100
Testing effectiveness (Phase 2)Looking for participantsNCT06478537
What this trial is testing

TPO-RA Treatment on Immune Tolerance Induction of ITP Patients With Sustained Platelet Recovery After Treatment Termination

Who this might be right for
Immune Thrombocytopenia
Peking Union Medical College Hospital 56
Testing effectiveness (Phase 2)Study completedNCT05279872
What this trial is testing

Zanubrutinib in Patients With ITP

Who this might be right for
Immune ThrombocytopeniaBruton Tyrosine Kinase
Peking University People's Hospital 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07669675
What this trial is testing

TPO-RA Plus Baricitinib vs. TPO-RA for ITP

Who this might be right for
ITP - Immune Thrombocytopenia
Peking University People's Hospital 100
Not applicableUnknownNCT02815176
What this trial is testing

Angiographic Characteristics of CSC, PCV Patients and Thrombotic Bio-markers

Who this might be right for
Central Serous ChorioretinopathyPolypoidal Choroidal Vasculopathy
Samsung Medical Center 100
Testing effectiveness (Phase 2)Study completedNCT03922308
What this trial is testing

Study of rADAMTS-13 (SHP655) in the Treatment of Participants With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

Who this might be right for
Acquired Thrombotic Thrombocytopenic Purpura (aTTP)
Shire 28
Testing effectiveness (Phase 2)UnknownNCT01637428
What this trial is testing

The Use of Intermittent Pneumatic Compression Device for Symptomatic Relief in Patients With Post Thrombotic Syndrome

Who this might be right for
Post Thrombotic Syndrome
Hadassah Medical Organization 20
Large-scale testing (Phase 3)Study completedNCT00362349
What this trial is testing

Ig NextGen 10% in Idiopathic Thrombocytopenic Purpura (ITP) Patients

Who this might be right for
Idiopathic Thrombocytopenic Purpura (ITP)
CSL Limited 19
Not applicableUnknownNCT04128358
What this trial is testing

Triple Therapy in Patients With Idiopathic Thrombocytopenic Purpura : What is Behind?

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Assiut University 180
Not applicableStudy completedNCT01561248
What this trial is testing

Study of Repetitive Intestinal Lavage in Patients With EHEC Associated Hemorrhagic Colitis

Who this might be right for
Hemolytic Uremic SyndromeHemorrhagic ColitisIntestinal Infectious Disease+1 more
Universitätsklinikum Hamburg-Eppendorf 33
Testing effectiveness (Phase 2)Looking for participantsNCT07710248
What this trial is testing

SG301-SC Injection Safety Study in Subjects With Primary ITP Patients

Who this might be right for
Primary Immune Thrombocytopenia
Hangzhou Sumgen Biotech Co., Ltd. 60
Large-scale testing (Phase 3)Study completedNCT04132050
What this trial is testing

A Clinical Study in Patients With Chronic Idiopathic Thrombocytopenic Purpura in R788

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Kissei Pharmaceutical Co., Ltd. 34
Not applicableLooking for participantsNCT07372170
What this trial is testing

Observational Study to Evaluate the Effectiveness of DOACS for Secondary Thrombosis Prevention in Low-risk Thrombotic APS Patients

Who this might be right for
Antiphospholipid Syndrome (APS)Venous Thrombosis (Disorder)Thrombophilia
Infanta Leonor University Hospital 600
Not applicableStudy completedNCT01770951
What this trial is testing

A Retrospective, Observational, Non-interventional Trial to Assess Eculizumab Treatment Effect in Patients With Atypical Hemolytic Uremic Syndrome (aHUS)

Who this might be right for
Atypical Hemolytic Uremic Syndrome (aHUS)
Alexion Pharmaceuticals, Inc. 30
Post-approval studies (Phase 4)Not Yet RecruitingNCT07840352
What this trial is testing

Safety And Field Evaluation of Plasma Lyophilized for Acute and Surgical Management Applications

Who this might be right for
CoagulopathyPlasma Transfusion Safety
Teleflex 867
Post-approval studies (Phase 4)UnknownNCT03771378
What this trial is testing

Efficacy and Safety of rhTPO and Eltrombopag in Patients With Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 96
Next Page